Renal cell carcinoma: Updates on treatment and management
Your valuable comments help us improve the quality of meetings and we are looking forward to hearing your thoughts. We would appreciate if you could kindly take a few minutes to answer the questions below. Thank you very much.
1. Please rate the overall organisation of the meeting:
2. Please rate the following meeting sessions in terms of content, delivery, and quality of discussion:
a) Presentation and discussion Understanding the impact of the CM9ER data *
b) Presentation and discussion Treatment choices in 1L RCC and therapeutic sequencing *
c) Case sharing How Cabo + Nivo fits into the treatment landscape *
d) Presentation and discussion Gaps in the data and opportunities for further clinical development *
3. Which topic(s) would you like to see covered in future meetings?
4. Any other comments?